3,4-Methylenedioxyphentermine
Appearance
(Redirected fromMethylenedioxyphentermine)
This articlerelies largely or entirely on asingle source.(August 2016) |
Names | |
---|---|
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-2-methylpropan-2-amine | |
Other names
3,4-Methylenedioxyphentermine;
3,4-Methylenedioxy-alpha,alpha-dimethyl-1-ethane | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChemCID
|
|
UNII | |
CompTox Dashboard(EPA)
|
|
| |
| |
Properties | |
C11H15NO2 | |
Molar mass | 193.246g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state(at 25 °C [77 °F], 100 kPa).
|
3,4-Methylenedioxyphentermine(MDPH) is a lesser-knownpsychedelic drug.MDPH was first synthesized byAlexander Shulgin.In his bookPiHKAL (Phenethylamines i Have Known And Loved),the dosage range is listed as 160–240 mg, and the duration as 3–5 hours.[1]MDPH's effects are very similar to those ofMDA:they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to2C-D.Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.
Legality
[edit]United Kingdom
[edit]This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[2]
See also
[edit]References
[edit]- ^MDPH entry inPiHKAL
- ^"UK Misuse of Drugs act 2001 Amendment summary".Isomer Design. Archived fromthe originalon 22 October 2017.Retrieved12 March2014.